ARTICLE | Clinical News
Vimizim elosulfase alfa regulatory update
December 15, 2014 8:00 AM UTC
BioMarin said Brazil and Australia approved Vimizim elosulfase alfa to treat mucopolysaccharidosis IVA (MPS IVA, Morquio’s syndrome), a rare inherited lysosomal storage disease. The recombinant human ...